Do Plasmablasts Express Cd27?

Do Plasmablasts express CD27?

Adult human peripheral blood CD19+ B cells contain 4 populations that differentially express CD20, CD27, CD38 and CD43. Plasmablasts (PB) are currently the most well-described peripheral blood B-cell population that spontaneously secretes antibody.

What is CD27+?

CD27 is a costimulatory molecule that upon binding to CD70 regulates survival and activation of T, B, and NK lymphocytes, and is important to promote generation of virus-specific CTLs and to induce NK cell cytotoxicity (Yang et al., 1996; van Gisbergen et al., 2011).

What are Plasmablasts?

In immunology, a “plasmablast” refers to a short-lived differentiation stage between a post germinal centre B-cell and a mature plasma cell. Plasmablasts retain a proliferative capability together with an almost fully mature plasma cell phenotype [1].

Do memory B cells express CD38?

CD38 is expressed on all naive B cells but is down-regulated on isotype-switched B cells from both the germinal centers (GCs) and the foci of Ab-forming cells which arise during the first weeks of the response.

Do plasma cells express HLA DR?

HLA-DR and CD45 expressions are also characteristics of long-living plasma cells, since a large fraction of CD138+ bone marrow plasma cells expresses HLA-class II (60%) or CD45 (65%).

Do Plasmablasts express CD19?

Both mouse and human plasma cells are commonly identified as CD19-Syndecan-1/CD138+ cells. Human plasma cells also express high levels of CD38, while mouse plasma cells also express Ly6k, Sca-1/Ly6, and CD98 and lose expression of B220/CD45 R.

What are CD45RA cells?

CD45RA T cells have “naive” characteristics of unresponsiveness to recall antigens and prominence in cord blood, while CD45RO T cells are considered “memory” T cells because they proliferate to recall antigens and increase following PHA activation of cord blood.

What is CD38 marker?

CD38 is a multi-functional transmembrane protein that is a lymphocyte receptor and a clinical marker for survival of patients with B-cell chronic lymphocytic leukemia (CLL) [1-5].